Avelumab: another active immune checkpoint inhibitor in non-small cell lung cancer

Transl Lung Cancer Res. 2017 Dec;6(Suppl 1):S41-S43. doi: 10.21037/tlcr.2017.10.15.
No abstract available

Publication types

  • Editorial
  • Comment